Long-Term Use of Alendronate Puts Some Patients at Risk for Fracture
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Long-Term Use of Alendronate Puts Some Patients at Risk for Fracture

NEW YORK -- June 27, 2008 -- There is new evidence linking risk for one kind of femoral stress fracture with long-term use of bisphosphonates.

The preliminary study followed 70 patients, 25 of whom were taking alendronate (Fosamax) for an average of 5 years. Among those receiving the therapy, 19 patients presented with 1 type of femoral stress fracture that resulted from little or no trauma. By comparison, the fracture type was only evident in 1 patient not receiving the therapy.

Furthermore, the average duration of alendronate use in those patients with the fracture pattern was significantly longer than in those who were not taking the therapy, at 6.9 years versus 2.5 years, respectively.

"While bisphosphonates like [alendronate] have been proven to successfully treat osteoporosis and other metabolic bone disease, we believe long-term use of these drugs may suppress the ability of bones to heal in some patients. As a consequence, patients with routine stress fractures are unable to properly heal, and minor damage can worsen until a serious fracture occurs," says the study's senior author, Dean G. Lorich, MD, Weill Cornell Medical College, New York-Presbyterian/Weill Cornell Medical Center, and the Hospital for Special Surgery, New York, New York.

SOURCE: New York-Presbyterian Hospital/Weill Cornell Medical Center

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities